Medibank stock reports FY26 profit growth as health expands

Published on 10/01/2026 at 07:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medibank stock generated AUD 636.8 million in underlying NPAT in FY26, up 2.9 percent. Health segment profit rose 31.3 percent to AUD 100.7 million.

Medibank, AU000000MPL3, Illustration mit AI erstellt.

Medibank stock is anchored by FY26 underlying net profit after tax of AUD 636.8 million, an increase of 2.9 percent from the prior year. The result gives investors a clear split screen: the core insurance business remains profitable, while health services are expanding faster. Motley Fool reported the figures on September 1, 2026, citing Medibank's full-year results released on August 20, 2026.

Health services outpace insurance

Medibank Health segment profit increased 31.3 percent to AUD 100.7 million in fiscal year 2026, while segment revenue reached AUD 634.8 million. The health services arm also expanded its primary care network to 169 clinics after the Better Medical acquisition.

Medical Republic reported on September 16, 2026, that health services revenue grew 30.8 percent in FY26. Primary care revenue rose 29.6 percent to AUD 316.5 million, while GP consultations increased 26.7 percent.

Insurance remains the earnings base

Health insurance revenue increased 4.6 percent to AUD 8.59 billion in FY26, and operating profit rose 3.8 percent to AUD 769.8 million. Resident policyholders increased by 22,100, or 1.1 percent, although growth was concentrated in lower-tier products.

The dividend also moved higher. Medibank declared a fully franked FY26 dividend of 19.2 cents per share, up 6.7 percent from the prior year, including a final dividend of 10.9 cents.

Prior close and market value

The Lang & Schwarz prior close was EUR 2.84 on September 29, 2026. Medibank had a market capitalization of AUD 12.5 billion on October 1, 2026, while the ASX 52-week range was AUD 4.06 to AUD 5.31.